Transcatheter Technologies is a developer of an aortic valve for aortic therapy. The company develops medical devices and implantation systems which helps to reduce the trauma of open-heart valve surgeries.

Transcatheter Technologies was acquired by Venus Medtech on April 15, 2016. With the acquisition, Venus Medtech greatly enhances its valve products presence in the global market.

Investment: Series A